About me
Dr. Weiner is an internationally-recognized medical oncologist specializing in gastrointestinal cancers. He is also an accomplished researcher developing novel immunotherapy treatments – essentially triggering the body’s own immune system to identify and destroy cancer. He is recognized for his laboratory and clinical research focusing on these new therapeutic approaches. Dr. Weiner wants to understand why some tumors become resistant to therapy and other forms of cancer immunotherapy, with the goal of developing new treatments to overcome that resistance. He lectures extensively on these forms of targeted therapies, which block the growth and spread of cancer.
He serves as director of the Georgetown Lombardi Comprehensive Cancer Center – Washington, D.C.’s only National Cancer Institute-designated comprehensive cancer center – and the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health throughout the region. Dr. Weiner is also associate vice president at Georgetown University Medical Center, chair of the oncology department at Georgetown University School of Medicine, and clinical director of cancer services at MedStar Georgetown University Hospital.
In these roles, Dr. Weiner is responsible for operations, development, research, clinical and educational missions. As the Institute’s director, he oversees the clinical operations of the MedStar Health cancer service line, and leads the advancement of clinical care and research programs spanning prevention, treatment, rehabilitation, survivorship and end-of-life care across the region. With Georgetown Lombardi serving as the Institute’s “research engine,” patients throughout the region have access to unmatched expertise and clinical trials closer to where they live and work.
Dr. Weiner previously served as chairman of the Medical Oncology Department and vice president for Translational Research at Fox Chase Cancer Center in Philadelphia, PA. He held an endowed chair in medical science and was the driving force behind developing an immunotherapy laboratory and clinical programs, as well as establishing the Center's medical oncology fellowship program. Dr. Weiner also served as professor in the Department of Medicine at Temple University School of Medicine.
Dr. Weiner's Philosophy of Care
We live in a time of great hope in the area of cancer therapy. Many new, important and life-changing treatments are now being developed. We are privileged to offer patients tomorrow's treatments today. And now, through the MedStar Georgetown Cancer Institute, we can extend that mission across the region. With this progress in mind, I strive to offer all my patients the best possible therapies for their diseases, always mindful that I am neither treating a disease nor a patient, but a person with a life, a family and a combination of hopes and fears.
Working at a great cancer program like this gives me the opportunity to collaborate with leading international experts to assure that my patients can benefit from the best possible care during the course of their journeys.
Clinical areas of focus
- Esophageal Cancer Treatment
- Gastrointestinal Cancer Treatment
- Liver Metastases Treatment
- Low Anterior Resection
Procedures I perform
- A1c Testing
- Adjuvant Hormone Therapy
- Akt Inhibitors
- Anemia Management
- Angiogenesis Inhibitors
- Antiangiogenic Therapy
- Aromatase Inhibitors
- Arthrocentesis
- Barium Enema
- Bavituximab
- Bioinformatics
- Blinatumomab
- Blood Banking
- Brca Gene Testing
- Cancer Biotechnology
- Cancer Research Institute
- Cancer Survivorship
- Cancer Systems Biology
- Cardiac Gene Expression
- Chemoradiation
- Chemotherapy Administration
- Cholecystectomy
- Cisplatin
- Clinical Pathology
- Clinical Trials
- Coagulopathy Management
- Cold Laser Therapy
- Colectomy
- Colorectal Cancer Treatment
- Community Health
- Crispr-Cas9
- Disease Prevention
- Embolization For Bleeding
- Endoscopic Mucosal Resection
- Enteroscopy
- Esophageal Cancer Treatment
- Fertility Counseling
- Gastrectomy
- Gastrointestinal Cancer Treatment
- Gemtuzumab Ozogamicin
- Genomic Instability
- Genomic Testing For Cancer
- Growth Hormone Management With Octreotide
- Health Outcomes Research
- Helicobacter Pylori Stool Test
- Hepatectomy
- Hepatic Artery Infusion
- Hepatoblastoma Treatment
- Hormone Regulation With Leuprolide
- Hormone Replacement Therapy
- Ileal Pouch-Anal Anastomosis
- Immunotherapy
- Intravenous (IV) Fluids
- Isolated Limb Perfusion
- Laparoscopic Revision Of Gastric Restrictive Procedure
- Lhrh Agonists
- Liquid Biopsy
- Liver Cancer Treatment
- Liver Metastases Treatment
- Low Anterior Resection
- Lynch Syndrome Testing
- Magnetic Resonance Imaging (MRI)
- Minimally Invasive Surgery
- Molecular Diagnostics
- Nateglinide
- Neoadjuvant Therapy
- Neratinib
- Nod-Like Receptor Monitoring
- Pancreatectomy
- Pancreatic Cancer Treatment
- Pegargiminase
- Pegilodecakin
- Peginterferon Alfa-2A
- Percutaneous Tumor Chemoembolization
- Performance Improvement
- Perianal Surgery
- Peripheral Blood Stem Cell Transplantation
- Personalized Care
- Pertuzumab
- Pet-Ct Scan
- Pharmacokinetics
- Pharmacological Treatment Of Hypertension
- Portosystemic Shunt
- Pre-Operative Conditioning
- Radiomics
- Removal Of Central Venous Access Device
- Rilotumumab
- Rituximab
- Robotic Surgery
- Selpercatinib
- Single Photon Emission Computed Tomography
- Sintilimab
- Stem Cell Gene Editing
- Stem Cell Therapy
- Stereotactic Ablative Radiotherapy
- Stivarga
- Synthetic Lethality
- Tertiary Cancer Prevention
- Tocilizumab (ACTEMRA) Treatment
- Tofacitinib (XELJANZ) Treatment
- Total Proctocolectomy
- Translational Medicine Research
- Transplant Immunology
- Trastuzumab
- Trastuzumab Emtansine
- Tumor Marker Testing
- Ultrasound
- Vaccinations
- Vectibix
- Wellness Services
- Whole-Exome Sequencing
- Ziv-Aflibercept
Practice locations
Distance from Change Location Enter your Location
3800 Reservoir Rd NW
Lombardi Cancer Center
Washington, DC, 20007
Insurance
This list represents the major payors accepted by MedStar Health. NOTE: Payor contracts change and not all plans associated with a payor may be covered. Payors may offer multiple plans. If you have a question related to your insurance, please contact your insurance plan directly. Contact information is located on your health insurance ID card. *Denotes limited participation. Specific providers and practices may NOT be participating. Please contact your insurance plan directly.
-
List of insurance plans we accept
- Aetna
- CareFirst BlueCross BlueShield of Maryland
- Cigna Health Care
- Kaiser Permanente*
- MedStar Select (Administered by CareFirst)
- United HealthCare
- Aetna
- CareFirst BlueCross BlueShield of Maryland
- Healthspring
- Humana
- Medicare & Railroad Medicare
- United HealthCare
- Aetna Better Health of Maryland *
- Medical Assistance/Medicaid
- MedStar Family Choice MD
- Priority Partners *
- United HealthCare Community Health Plan MD
- Wellpoint MD
- AmeriHealth Caritas
- Health Services For Children With Special Needs (HSCSN)
- Medical Assistance/Medicaid
- MedStar Family Choice DC
- Johns Hopkins Employer Health Programs *
- Johns Hopkins US Family Health Plan *
- MultiPlan
- Private Healthcare Systems
- Tricare/Humana Military
- VA Community Care Network (VACCN)
Videos
Education
Board Certification: American Board of Internal Medicine, Internal Medicine
Fellowship: Tufts Medical Center (1984)
Fellowship: Tufts Medical Center (1982)
Residency: University of Vermont Medical Center (1981)
Internship: University of Vermont Medical Center (1978)
Medical School: Icahn School of Medicine at Mount Sinai (1977)
Awards
- Castle Connolly Top Doctors, 2021
- National Academy of Inventors Fellow, 2017-2018
- Recognition for Outstanding Contribution to Innovation and Commercialization, Georgetown University, Office of Technology, 2016
- Fellow, American College of Physicians, 2010
- America’s Top Oncologists, 2009
- America’s Top Doctors for Cancer, 2007 – Present
- Philadelphia Magazine's Top Docs, 2002; 2004 – 2007
- Who's Who in Medicine and Healthcare, 2002 - 2005
- G. Morris Dorrance, Jr. Endowed Chair in Medical Science, 2002
- American Association for Cancer Research Scientist-Survivor Program Award, 2002
- American Cancer Society - Southeast Region Scientific Research Award, 2002
- Janssen Pharmaceutical Research Foundation: Research Award for Outstanding Contributions to the Field of Receptor Targeted Therapy, 2001
- Best Doctors in America, 2000-2011
- National Cancer Institute Clinical Investigator Award, 1986
- American Cancer Society Career Development Award, 1985
Hospital affiliations
News and publications
- Georgetown Lombardi Comprehensive Cancer Center Receives Coveted ‘Comprehensive Cancer Center’ Status from National Cancer Institute
- Georgetown Lombardi Director Louis Weiner Receives AACR 2019 Distinguished Public Service Award
- Georgetown Lombardi’s Louis M. Weiner, MD, Named A National Academy of Inventors Fellow
- MedStar Health Collaborates with Inivata to Advance Precision Cancer Genomics Using Liquid Biopsy
- MedStar Health Taps Louis M. Weiner to Lead MedStar Georgetown Cancer Institute
- Enhancing Antibody Dependent Cellular Cytotoxicity (ADCC) as an Anti-Tumor Mechanism
- Manipulating Antibody Structure to Improve Selective Tumor Targeting
- Identifying Tumor Cell-Based Determinants of Antibody-Mediated Cell Killing
- Immunoconjugates for Cancer Therapy
- Antibody-initiated Cancer Immunotherapy
- Click here for a complete list of his research papers and scientific contributions.
